What is HIV?
HIV stands for human immunodeficiency virus. HIV destroys
certain white blood cells called CD4+ T cells. These cells
are critical to the normal function of the human immune
system, which defends the body against illness. When HIV
weakens the immune system, a person is more susceptible
to developing a variety of cancers and becoming infected
with viruses, bacteria and parasites.
What is AIDS?
AIDS stands for acquired immunodeficiency syndrome.
A person who tests positive for HIV can be diagnosed
with AIDS when a laboratory test shows that his or her
immune system is severely weakened by the virus or when
he or she develops at least one of about 25 different
opportunistic infections -- diseases that might not
affect a person with a normal immune system but that
take advantage of damaged immune systems.
How is HIV detected?
Several different types of laboratory tests can be used
to determine whether a person is HIV-positive. It is
impossible to look at someone and know whether he or
she is HIV-positive. Most tests used to screen for the
virus detect HIV antibodies -- proteins the body produces
to fight off the infection -- in blood or oral fluid
samples.
How does HIV cause AIDS?
HIV destroys CD4+ T cells that are important to the
normal function of the human immune system. As the virus
destroys these cells, HIV-positive people are susceptible
to illnesses that generally do not affect people with
healthy immune systems. According to studies including
thousands of people, most HIV-positive people are infected
with the virus for years before it does enough damage
to the immune system to make them susceptible to AIDS-related
diseases. Tests are available to measure the amount
of HIV in the blood – the viral load – and those with
higher viral loads are more likely to develop AIDS-related
diseases and to experience a decline in their CD4+ T
cells. Reducing the amount of virus in the body with
antiretroviral medications can dramatically slow the
destruction of a person's immune system and the progression
of illness.
Why do some people make statements
that HIV does not cause AIDS?
The HIV/AIDS pandemic has attracted much attention both
within and outside of the medical and scientific communities,
possibly because of the many social issues related to
HIV/AIDS, including sexuality, drug use and poverty.
Although the scientific evidence is overwhelming and
compelling that HIV is the cause of AIDS, the disease
process is still not completely understood. This incomplete
understanding has led some people to make statements
that AIDS is not caused by an infectious agent or is
caused by a virus that is not HIV. This is not only
misleading, but may have dangerous consequences. Both
the U.S. National Institutes of Health and UNAIDS offer
explanations of why HIV leads to AIDS:
- NIH How HIV Causes AIDS and The
Evidence That HIV Causes AIDS
- UNAIDS Questions & Answers
How long does it take for HIV to
cause AIDS?
The time between HIV infection and progressing to AIDS
differs for each person and depends on many factors,
including a person's health status and their health-related
behaviors. With a healthy lifestyle, the time between
HIV infection and developing AIDS-related illnesses
can be 10 to 15 years, sometimes longer. Antiretroviral
therapy can slow the progression of HIV to AIDS by decreasing
the amount of virus in a person's body. There also are
other medical treatments that can prevent or cure some
of the illnesses associated with AIDS, although the
treatments do not cure HIV or AIDS. As with other diseases,
early detection of HIV infection allows for more options
for treatment and preventive health care.
What are some of the symptoms of
HIV infection and AIDS?
Once infected with HIV, a person may or may not experience
any symptoms. People who do experience symptoms might
have a flu-like illness within one or two months after
infection. Symptoms can include fever, headache, tiredness
and/or enlarged lymph nodes. These symptoms usually
disappear within a week to a month and are often mistaken
for the symptoms of more common viral infections, like
a cold. More persistent or severe symptoms might not
appear for several years after a person is first infected
with HIV. This period of "asymptomatic" infection
is highly individual. Some people might begin to have
symptoms within a few months, while others might be
symptom-free for more than 10 years.
As the immune system is weakened by
HIV, several complications and symptoms could begin
to occur. These symptoms might be made worse if the
HIV-positive person is not getting the care and services
they need. For many people, the first signs of infection
are enlarged lymph nodes or "swollen glands"
that may be inflamed for several months. As the immune
system is weakened by HIV, several complications and
symptoms could begin to occur. These symptoms could
be made worse if the HIV-positive person is not getting
the care and services they need. For many people, the
first signs of infection are enlarged lymph nodes or
"swollen glands" that may be inflamed for
several months. Other symptoms that HIV-positive people
might experience months to years before receiving an
AIDS diagnosis include:
- Lack of energy
- Weight loss
- Frequent fevers and sweats (sometimes
known as "night sweats")
- Persistent or frequent yeast infections
(oral or vaginal)
- Persistent skin rashes or flaky
skin
- Pelvic inflammatory disease in women
that does not respond to treatment
- Short-term memory loss
- Frequent and severe herpes infections
that cause mouth, genital, or anal sores, or a painful
nerve disease called shingles.
Both men and women experience many
of the same symptoms from HIV infection. However, women
also experience unique complications that are primarily
gynecologic. These could include recurrent vaginal yeast
infections, severe pelvic inflammatory disease (PID)
or human papillomavirus (HPV) infections. Other vaginal
infections might occur more frequently and with greater
severity in HIV-positive women (compared with HIV-negative
women), including bacterial vaginosis and common sexually
transmitted infections such as gonorrhea, chlamydia,
and trichomoniasis. HIV-positive women also might experience
disruptions or other irregularities in their menstrual
cycles.
The signs and symptoms of HIV/AIDS
are similar to the symptoms of many other illnesses.
The only way to determine HIV infection is to be tested.
Is there a cure for HIV/AIDS?
There is no known cure for HIV/AIDS. There are medical
treatments that can slow down the rate at which HIV
weakens the immune system. There are other treatments
that can prevent or cure some of the illnesses associated
with AIDS. Researchers are testing a variety of preventive
and curative vaccine candidates, but a successful vaccine
likely is years away.
What is the link between HIV and
tuberculosis?
The HIV epidemic is largely responsible for the growing
number of TB cases in many parts of the world. HIV weakens
the cells in the immune system that are needed to fight
TB; up to half of all people living with HIV/AIDS eventually
develop TB. Worldwide, TB is the leading cause of death
among HIV-positive people.
What is the link between HIV and
sexually transmitted diseases?
People with a sexually transmitted disease are far more
vulnerable than others to becoming infected with HIV.
For example, genital ulcers caused by herpes create
an entry point for HIV. Even when the STD causes no
breaks in the skin or open sores, the infection can
cause an immune response in the genital area that can
make HIV transmission more likely.
In addition, HIV-positive people are
more vulnerable to acquiring sexually transmitted diseases
than HIV-negative people because their immune systems
are weakened. If an HIV-positive person is infected
with another STD, that person is three to five times
more likely than other HIV-positive people to transmit
HIV through sexual contact.
How is HIV transmitted?
HIV transmission can occur when blood, semen, pre-seminal
fluid, vaginal fluid or breastmilk from an HIV-positive
person enters the body of an HIV-negative person. HIV
can enter the body through a vein, the lining of the
anus or rectum, the lining of the vagina and/or cervix,
the opening to the penis, the mouth, other mucous membranes
-- such as the eyes or inside of the nose -- or cuts
and sores. Intact, healthy skin is an excellent barrier
against HIV and other viruses and bacteria.
Worldwide, the most common way that
HIV is transmitted is through sexual transmission, including
anal, vaginal or oral sex with an HIV-positive person.
HIV also can be transmitted by sharing needles or injection
equipment with an injection drug user who is HIV-positive,
or from an HIV-positive woman to her infant before or
during birth or through breastfeeding after birth. HIV
also can be transmitted through receipt of infected
blood or blood clotting factors.
Which body fluids transmit HIV?
Blood, semen, vaginal fluid, breastmilk, and other body
fluids containing blood taken from HIV-positive people
can contain high concentrations of HIV. The virus also
might be present in the fluid surrounding the brain
and the spinal cord, fluid surrounding bone joints and
fluid surrounding a fetus of an HIV-positive pregnant
woman.
HIV has been found in the saliva and
tears of some HIV-positive people but in very low quantities.
A small amount of HIV in a body fluid does not necessarily
mean that HIV can be transmitted by that body fluid.
HIV has not been recovered from the sweat of HIV-positive
people. Contact with saliva, tears or sweat has never
been shown to result in HIV transmission.
How is HIV not transmitted?
HIV is not easily passed from one person to another.
The virus does not survive well outside of the body.
HIV cannot be transmitted through casual or everyday
contact such as shaking hands or hugging. Sweat, tears,
vomit, feces and urine do contain small amounts of HIV,
but they have not been reported to transmit the disease.
Mosquitoes and other insects do not transmit HIV.
How can HIV transmission be prevented?
The best way to avoid HIV infection is to avoid behaviors
that would involve exposure to infected body fluids,
including unprotected sexual intercourse or sharing
needles to inject drugs. If avoiding such behaviors
is not possible, numerous health organizations have
determined that the use of latex condoms during vaginal,
anal or oral intercourse can significantly reduce the
risk of HIV transmission; HIV-positive pregnant women
can take medications that can reduce the risk of HIV
transmission to her child; and injection drug users
should not share needles or injection equipment.
How effective are latex condoms
in preventing HIV?
Latex condoms, when used consistently and correctly,
are highly effective in preventing transmission of HIV.
Laboratory studies have found that HIV does not pass
through intact latex condoms even when they are stretched
or stressed, according to the World Health Organization.
Prospective studies looking at couples in which one
partner is HIV-positive and the other is not have shown
that, with consistent condom use, less than 1% of the
HIV-negative people became infected annually. In 2000,
representatives of four U.S. government agencies (U.S.
Agency for International Development, Food and Drug
Administration, Center for Disease Control and Prevention,
National Institutes of Health) concluded in a report
that, based on an analysis of published studies, male
condoms significantly reduce the risk of HIV transmission
for both men and women during vaginal intercourse when
used correctly in every encounter.
Why is injection drug use a risk
for HIV transmission?
At the start of every injection, blood is introduced
into the needle and syringe. Therefore, a needle and
syringe that an HIV-positive person uses can contain
blood that contains the virus. The reuse of a blood-contaminated
needle or syringe by another drug injector carries a
high risk of HIV transmission because infected blood
can be injected directly into the bloodstream.
Sharing other drug-using equipment
also can be a risk for spreading HIV. Infected blood
can be introduced into drug solutions through using
blood-contaminated syringes to prepare drugs; reusing
water; reusing bottle caps, spoons, or other containers
used to dissolve drugs in water and to heat drug solutions;
or reusing small pieces of cotton or cigarette filters
used to filter out particles that could block the needle.
Are health care workers at risk
of getting HIV on the job?
The risk of health care workers being exposed to HIV
on the job is very low, especially if they carefully
follow "universal precautions," which are
meant to protect them from exposure to all body fluids.
The main risk of HIV transmission for health care workers
on the job is through accidental injuries from needles
and other sharp instruments that might be contaminated
with the virus. However, even this risk is small. Scientists
estimate that the risk of infection from a needlestick
is less than 1%, a figure based on the findings of several
studies of health care workers who received punctures
from HIV-contaminated needles or were otherwise exposed
to HIV-contaminated blood.
If a health care worker is exposed
to HIV-contaminated bodily fluid on the job, they can
take medications to help reduce their risk of infection.
These treatments, called post-exposure prophylaxis,
or PEP, usually involve taking a four-week regimen of
two or three antiretroviral drugs. The health worker
should undergo a baseline test for HIV infection and
begin PEP as quickly as possible after the exposure,
usually within 36 hours. PEP guidelines are available
from the U.S. Centers for Disease Control and Prevention.
Are patients in a health care setting
at risk of getting HIV?
While unsafe sexual practices are responsible for the
majority of HIV infections worldwide, UNAIDS estimates
that unsanitary medical practices -- including the reuse
of needles and syringes -- are responsible for as much
as 2.5% of HIV cases in sub-Saharan Africa. Although
major efforts have been undertaken to improve unsanitary
medical practices worldwide, more needs to be done to
thoroughly test blood donations and eliminate risky
injections. While all countries recognize the importance
of blood safety and screen blood for HIV antibodies,
in many developing countries screening is routine only
in urban settings. Injections should be used only when
medically necessary and should be given with single-use
equipment that is disposed of safely. Health care workers
should practice careful infection control procedures
in order to protect patients and themselves from possible
HIV infection in medical settings.
Can HIV be transmitted through casual
contact (shaking hands, hugging, using a toilet, drinking
from the same glass, or sneezing and coughing)?
HIV is not transmitted through day-to-day contact in
workplaces, schools, or social settings. HIV is not
transmitted through shaking hands, hugging, or casual
kissing. A person cannot become infected from touching
a toilet seat, a drinking fountain, a door knob, dishes,
drinking glasses, food, or pets.
HIV is not an airborne or foodborne
virus, and it does not live long outside the body. HIV
can be found in blood, semen, or vaginal fluid of an
HIV-positive person.
Can HIV be transmitted through mosquitoes?
No, mosquitoes do not transmit HIV. When mosquitoes
feed on blood from a person they only inject their saliva,
which serves as a lubricant and allows the insect to
draw blood more easily. In addition, HIV does not reproduce
or survive inside mosquitoes, unlike organisms that
are transmitted via insect bites.
How well does HIV survive outside
the body?
HIV does not survive for very long outside of the human
body. HIV is unable to reproduce outside its living
host, except under laboratory conditions. Therefore,
it does not spread or maintain infectiousness outside
its host.
Where did HIV come from?
In 1999, scientists reported that they had discovered
the origin of HIV-1. They identified a subspecies of
chimpanzees native to West Equatorial Africa as the
original source of the virus. The virus most likely
was introduced into the human population when hunters
were exposed to the infected blood of non-human primates.
More information about the origin of HIV is available
from the National Institute of Allergy and Infectious
Diseases.
How many people have HIV/AIDS?
UNAIDS estimates that 39.4 million people were living
with HIV/AIDS worldwide as of the end of 2004, more
than ever before.
What HIV/AIDS statistics are the
most reliable?
UNAIDS and the World Health Organization provide the
most extensive set of statistics related to the global
epidemic. The statistics are compiled in consultation
with country-level experts and international epidemiologists.
Every country keeps its own record of the number of
HIV/AIDS cases and some countries' methods of collecting
information are more complete than others. More information
about how UNAIDS and WHO calculate HIV/AIDS estimates
is available on the UNAIDS Web site.
What do endemic, epidemic and pandemic
mean?
Endemic is the constant presence of a disease or infectious
agent in a certain geographic area or population group.
Epidemic is the rapid spread of a disease in a specific
area or among a certain population group. Pandemic is
a worldwide epidemic; an epidemic occurring over a wide
geographic area and affecting a large number of people.
What is ARV?
ARV stands for antiretroviral. Antiretroviral medications
are designed to inhibit the reproduction of HIV in the
body. If ARV treatment is effective, the deterioration
of the immune system and the onset of AIDS can be delayed
for years. It is recommended that ARV drugs be used
in combinations of at least three drugs.
What is HAART?
HAART stands for highly active antiretroviral therapy.
It is the combination of at least three ARV drugs that
attack different parts of HIV or stop the virus from
entering blood cells. Even among people who respond
well to HAART, the treatment does not get rid of HIV.
The virus continues to reproduce but at a slower pace.
What is drug resistance?
Drug resistance occurs when a virus is able to adapt,
grow and multiply even in the presence of drugs that
usually kill it. Drug resistance reduces the ability
of ARV drugs to block the replication of HIV. In some
people on HAART, the virus mutates and becomes highly
resistant to current medications.
What is ABC in terms of HIV prevention?
ABC stands for Abstinence, Be faithful to a single partner
and Condom use. Certain organizations and governments
promote the ABC prevention message as a means to stop
the spread of HIV.
What is the Global Fund to Fight
AIDS, Tuberculosis and Malaria?
The Global Fund to Fight AIDS, Tuberculosis and Malaria,
an independent organization, was created to increase
resources to fight three of the world's most devastating
diseases and to direct those resources to areas of greatest
need. The Global Fund -- which is a partnership between
governments, civil society, the private sector and affected
communities -- was created in 2001 at the urging of
U.N. Secretary-General Kofi Annan. Governments, foundations,
corporations not-for-profit organizations, and individuals
have pledged about $6 billion to the Global Fund, payable
through 2008.
What is the 3 by 5 Initiative?
The World Health Organization launched the 3 by 5 Initiative
in 2003. The campaign aims to have three million HIV-positive
people in developing countries on antiretroviral drug
treatment by the end of 2005. According to WHO, of the
almost six million HIV-positive people in developing
countries who were in need of ARV treatment as of the
end of 2004, only 700,000 had access. WHO views the
campaign as a step toward achieving universal access
to ARV treatment.
What is absorptive capacity?
Absorptive capacity refers to the ability of developing
countries to efficiently spend foreign aid money. Given
the limitations of health systems in some developing
countries, it can be challenging to process, disperse
and manage outside assistance, especially since many
developing countries receive aid from numerous donors,
each with their own preferences and requirements.
How many women in the world today
are living with HIV?
UNAIDS estimates that 17.6 million women between the
ages of 15 and 49 are living with HIV/AIDS, accounting
for nearly half of the almost 40 million HIV cases worldwide,
and up from 41% in 1997. In some of the most affected
countries and for younger populations, HIV-positive
women outnumber HIV-positive men. In sub-Saharan Africa,
57% of adults with HIV are women and young women account
for 76% of 15- to 24-year-olds living with HIV. In the
regions hardest hit by the epidemic, HIV is up to six
times as prevalent among young women as among their
male peers.
The number of HIV cases among women
is rising in all areas. In higher-income countries,
the percentage of HIV-positive women is growing and
is most pronounced in marginalized sections of populations,
including minorities, immigrants and refugees. In the
United States, the proportion of AIDS cases among women
has more than tripled since 1986, and HIV is the leading
cause of death for African-American women ages 25 to
34.
Why are young women at a higher
risk of HIV infection than young men?
Many young women lack information about sexual and reproductive
health and disease prevention. In countries with generalized
epidemics, the majority of women ages 15 to 24 do not
have access to information or resources about reproductive
health and HIV/AIDS. Young women may also lack access
to health care and education. In addition, young women
are among the most vulnerable because their genital
tracts have less mature tissue, which may be more easily
torn, and they are often victims of coercive or forced
sex.
What factors make women more vulnerable?
A combination of biological, social, cultural and economic
factors contribute to women's increased vulnerability
to HIV infection. In particular, gender inequalities
prevent women from asserting power over their own lives
and controlling the circumstances that increase their
vulnerability to infection, particularly in the context
of sexual relationships. Women are also physiologically
more susceptible to becoming infected with HIV than
men.
What biological factors make women
more vulnerable?
Researchers believe that women are biologically more
susceptible to HIV infection from heterosexual sex than
men. The female genital tract has a greater exposed
surface area than the male genital tract; therefore
women may be prone to greater risk of infection with
every exposure. Male-to-female HIV transmission is estimated
to be twice as likely as female-to-male transmission
in a single act of vaginal intercourse. Younger women
might be even more biologically vulnerable to HIV infection
because they have less mature tissue and are often victims
of coercive or forced sex.
What social and cultural factors
make women more vulnerable?
Social and cultural norms contribute to the unequal
status of women in societies, which facilitates the
spread of diseases such as HIV. In their sexual relationships,
women are often denied the power to make decisions that
may lower their risk of HIV infection. Social norms
may restrict women's ability to negotiate sex with a
condom, demand fidelity in a relationship or seek information
about protection, treatment or health care. The unequal
power balance between men and women puts women at a
greater risk of HIV infection. In some societies, social
norms may dictate that women remain monogamous, while
men may be allowed and even encouraged to engage in
sex with multiple partners.
What economic factors make women
more vulnerable?
Poverty and the reliance on men for economic support
compound women's risk of HIV infection. Women might
engage in unsafe sex or commercial sex work as a means
of survival or to support their families. Women’s financial
and material dependence on men often makes it difficult
or impossible for them to take control of their sexual
relationships.
What female-initiated preventive
technologies already exist?
Although women make up half of the HIV-positive adults
worldwide and HIV is transmitted primarily through heterosexual
intercourse worldwide, a female-controlled HIV prevention
method currently is not widely available. The female
condom is the first and only female-initiated barrier
to infection. Unfortunately, many women in developing
countries do not have access to the female condom, which
is not as readily available as the male condom and often
is more expensive. In addition, using the female condom
might involve negotiation with a male partner. Microbicides,
chemical compounds in the form of gels, films, sponges,
lubricants or suppositories that women could use before
sex to block HIV transmission, are under development.
Microbicides would provide an important new female-controlled
preventive technology.
What new preventive technologies
are in development?
Researchers currently are developing new technologies
such as microbicides and vaccines to help prevent HIV
infection. Microbicides are chemical compounds in the
form of gels, films, sponges, lubricants or suppositories
that women could use before sex to block HIV transmission.
An effective microbicide would kill HIV in semen, block
the virus from attaching to a target cell or prevent
HIV from multiplying if the virus enters a target cell.
A preventive HIV/AIDS vaccine
would elicit an immune response to protect the body
from HIV infection. A vaccine would be administered
orally or more likely through injection. Microbicides
and vaccines are tools that potentially could be used
without partner negotiation, which could grant women
greater power over their own sexual health. It is also
a possibility that a partially effective microbicide
and a partially effective vaccine could be used in combination
to prevent HIV infection. However, it is difficult to
estimate how long it will take before an effective microbicide
or vaccine is available on the world market, although
an effective microbicide probably will be available
before a vaccine.
Source www.cdc.gov
|